PENUMBRA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 204.4 USD | -0.53% |
|
+0.83% | -18.74% |
Chart calendar Penumbra, Inc.
742e0b26bee316e4a3c51c05baa.WoSdzH2-USZlu-9jmUKsYsw4g3eZeTReHR89KQ40kZ8.KLLTliLUC1M0joY11BbNCZZe9B_zClY2LHBKZTdOpM4e7cm9EehpbjLBiA~92c7c70433455d0557d8e50d52271466
Upcoming events on Penumbra, Inc.
Past events on Penumbra, Inc.
| 23/02/2024 03:00 am | Q4 2023 Earnings Call |
| 23/02/2024 02:35 am | Q4 2023 Earnings Release |
| 08/01/2024 09:45 pm | JPMorgan Healthcare Conference |
| 29/11/2023 12:00 am | Piper Sandler Healthcare Conference |
| 03/11/2023 02:00 am | Q3 2023 Earnings Call |
| 03/11/2023 01:35 am | Q3 2023 Earnings Release |
| 12/09/2023 11:30 pm | Baird Global Healthcare Conference |
| 12/09/2023 11:30 pm | Baird Global Healthcare Conference |
| 06/09/2023 05:30 pm | Wells Fargo Healthcare Conference |
| 09/08/2023 06:30 pm | Canaccord Genuity Growth Conference |
| 02/08/2023 02:00 am | Q2 2023 Earnings Call |
| 02/08/2023 01:35 am | Q2 2023 Earnings Release |
| 07/06/2023 07:50 pm | William Blair Growth Stock Conference |
| 31/05/2023 11:30 pm | Annual General Meeting |
| 16/05/2023 09:00 pm | RBC Global Healthcare Conference |
| 09/05/2023 11:10 pm | Bank of America Healthcare Conference |
| 03/05/2023 02:00 am | Q1 2023 Earnings Call |
| 02/05/2023 09:35 pm | Q1 2023 Earnings Release |
| 02/03/2023 09:30 pm | Citi Healthcare Services Medtech Tools & HCIT Conference |
| 24/02/2023 03:00 am | FY 2022 Earnings Call |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 547 544 0.7% | 560 550 1.96% | 748 738 1.3% | 847 845 0.26% | 1 059 1 061 -0.2% | 1 246 |
|
EBITDA Million USD | Released Forecast Spread | 55,6 53,5 4.04% | 15,5 7,85 97.24% | 51,5 62,4 -17.49% | 38,7 37,7 2.71% | 129 122 5.47% | 173 |
|
EBIT Million USD | Released Forecast Spread | 47,5 46,3 2.55% | 2,60 -23,3 111.13% | 35,0 41,7 -16.05% | 14,4 14,1 2.5% | 101 98,2 3.12% | 138 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 50,1 49,0 2.32% | 0,00 0,00 - | -10,5 11,4 -192.53% | 3,89 5,86 -33.62% | 79,7 84,6 -5.87% | 136 |
|
Net income Million USD | Released Forecast Spread | 48,5 38,9 24.57% | -15,7 -23,1 32.03% | 5,28 16,3 -67.58% | -2,00 5,12 -139.11% | 91,0 71,8 26.61% | 106 |
|
EPS USD | Released Forecast Spread | 1,34 1,08 24.07% | -0,44 -0,63 30.16% | 0,14 0,44 -67.82% | -0,05 0,13 -137.74% | 2,32 1,85 25.45% | 2,76 |
| Announcement Date | 25/02/20 | 23/02/21 | 22/02/22 | 23/02/23 | 22/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 204 194 5% | 204 195 4.35% | 208 206 1.02% | 214 212 0.64% | 221 217 1.93% | 241 230 5.09% | 261 253 3.26% | 271 265 2.19% | 285 287 -0.65% | 276 | 301 | 323 | 345 | 320 |
|
EBITDA Million USD | Released Forecast Spread | 8,24 13,6 -39.29% | 3,47 7,89 -56.11% | 5,79 4,67 23.89% | 14,0 6,43 118.3% | 13,7 14,1 -2.87% | 17,0 14,1 20.17% | 27,0 22,6 19.36% | 40,2 30,2 33.03% | 44,4 41,6 6.89% | 25,7 | 36,7 | 53,1 | 57,9 | 46,3 |
|
EBIT Million USD | Released Forecast Spread | 2,49 7,67 -67.57% | -2,26 1,61 -240.13% | 1,65 -0,78 311.71% | 7,81 1,54 407.47% | 7,21 8,43 -14.45% | 10,4 5,93 75.14% | 20,3 13,6 49.11% | 33,2 21,8 52.4% | 37,4 35,1 6.73% | 17,0 | 28,9 | 42,7 | 48,8 | 38,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -41,0 -19,1 -114.98% | -5,10 2,05 -348.75% | -1,17 0,58 -301.35% | 3,04 1,59 91.46% | 7,13 7,98 -10.7% | 8,65 5,50 57.19% | 19,5 13,5 44.74% | 13,3 20,5 -35.2% | 38,2 33,6 13.52% | 18,1 | 28,9 | 40,6 | 48,3 | 36,9 |
|
Net income Million USD | Released Forecast Spread | -24,6 -13,6 -81.13% | 0,08 1,59 -95.04% | -3,69 0,44 -941.2% | -2,27 1,20 -288.72% | 3,88 6,16 -37.07% | 8,56 4,36 96.59% | 19,0 10,9 74.41% | 9,21 16,2 -42.95% | 54,2 27,4 97.86% | 12,3 | 23,2 | 32,0 | 38,2 | 30,4 |
|
EPS USD | Released Forecast Spread | -0,66 -0,36 -83.33% | 0,00 0,04 - | -0,10 0,01 -887.4% | -0,06 -0,24 74.52% | 0,10 0,16 -37.62% | 0,22 0,11 96.69% | 0,48 0,28 72.57% | 0,23 0,43 -45.9% | 1,38 0,71 93.64% | 0,31 | 0,59 | 0,81 | 0,97 | 0,77 |
| Announcement Date | 22/02/22 | 03/05/22 | 04/08/22 | 03/11/22 | 23/02/23 | 02/05/23 | 01/08/23 | 02/11/23 | 22/02/24 | - | - | - | - | - |
| 29/04/2024 | SHENZHEN YHLO BIOTECH CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | INARI MEDICAL, INC.: Q1 2024 Earnings Release |
| 02/05/2024 | IRADIMED CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | NOVOCURE LIMITED: Q1 2024 Earnings Release |
| 06/05/2024 | SHOCKWAVE MEDICAL, INC.: Q1 2024 Earnings Release |
| 07/05/2024 01:39 am | SI-BONE, INC.: Q1 2024 Earnings Release |
| 08/05/2024 01:35 am | MASIMO CORPORATION: Q1 2024 Earnings Release |
| 08/05/2024 01:35 am | TREACE MEDICAL CONCEPTS, INC.: Q1 2024 Earnings Release |
| 08/05/2024 01:35 am | PENUMBRA, INC.: Q1 2024 Earnings Release |
| 08/05/2024 | CHEMOMETEC A/S: Q3 2024 Earnings Release |
Past sector events for Penumbra, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PEN Stock
- Calendar Penumbra, Inc.
